1. Home
  2. ALKT vs NVCR Comparison

ALKT vs NVCR Comparison

Compare ALKT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkami Technology Inc.

ALKT

Alkami Technology Inc.

HOLD

Current Price

$18.09

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.06

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKT
NVCR
Founded
2007
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
ALKT
NVCR
Price
$18.09
$15.06
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$28.57
$28.08
AVG Volume (30 Days)
1.3M
1.8M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$152,159,000.00
$655,353,000.00
Revenue This Year
$21.85
$7.72
Revenue Next Year
$16.90
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
35.68
8.28
52 Week Low
$13.98
$9.82
52 Week High
$26.89
$21.45

Technical Indicators

Market Signals
Indicator
ALKT
NVCR
Relative Strength Index (RSI) 55.72 44.54
Support Level $15.16 $14.85
Resistance Level $19.31 $15.46
Average True Range (ATR) 0.79 1.12
MACD 0.02 -0.16
Stochastic Oscillator 78.88 3.67

Price Performance

Historical Comparison
ALKT
NVCR

About ALKT Alkami Technology Inc.

Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: